Evidence map›Paper›PMID 37654835›Full record

ArticleBioinformation2022

Anti-cancer activity of

Yesudass Antony Prabhu, Chinnasamy Balalakshmi, Muthu Vijayasarathy, Kumar Praveen Kumar, Piramanayagam Shanmughavel, Samiappan Kavitha

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yesudass Antony PrabhuDepartment of Biochemistry, Rathnavel Subramaniam College of Arts and Science, Bharathiar University, Coimbatore - 641402, India.
Chinnasamy BalalakshmiDepartment of Nanoscience and Technology, Alagappa University, Karaikudi - 630003, India.
Muthu VijayasarathyDepartment of Microbiology, Thiagarajar College of Arts and Science, Madurai, India.
Kumar Praveen KumarDepartment of Bioinformatics, Bharathiar University, Coimbatore - 641046, India.
Piramanayagam ShanmughavelDepartment of Bioinformatics, Bharathiar University, Coimbatore - 641046, India.
Samiappan KavithaDepartment of Biochemistry, Rathnavel Subramaniam College of Arts and Science, Bharathiar University, Coimbatore - 641402, India.
Bharathiar University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive research on the mutant P53 protein has identified its pivotal role in anti-apoptosis mechanisms, drug resistance, and cancer progression in OSCC. The mass spectrum revealed the pharmacologically significant bioactive compounds reported for the first time in C cainito. Molecular docking investigation has identified four potential new P53 inhibitors compared with the standard P53 inhibitors. Hence, this analysis reinforces the likelihood of anti-cancer activities in

Indexed as

C. cainitomolecular dockingmutant P53 inhibitorsOSCC

Identifiers

PMID37654835
PMCPMC10465767
OpenAlexW4313822715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.